跳转至

情绪强化

◀返回

情绪强化（也被称为情感强化）[1] 被定义为一个人当前情绪状态的强度增加，超过了正常水平哦[2][3][4]。

这和认知欣快或焦虑等其他主观效应不太一样，这种效应不会不顾一个人当前的心态和心理稳定性而主动引发特定的情绪。相反，它是被动地放大和强化一个人在摄入药物之前或该效应发作之前已经感觉到的真实情绪呢。这意味着情绪强化既可以向好的方向发展，也可能向坏的方向发展哦[1][2][4][5][6]。如果要在治疗环境中使用迷幻剂，特别是目标是产生宣泄时，这种效应突显了情景与心境的重要性[1][3][6]。

举个栗子，一个当时感觉有点焦虑或情绪不稳定的人，可能会被强化的负面情绪、妄想和困惑压垮呢。相反，一个感觉普遍积极和情绪稳定的人，更有可能被情绪上的欣快感、幸福感和普遍满足感所包围。在情绪强化下感受到的情绪状态的强度可以塑造整个旅程的基调，并使使用者倾向于产生其他效应，比如积极状态下的躁狂或联结感，以及消极状态下的思维循环或厄运感[4]。不过，强烈的消极或困难情绪仍可能在治疗环境中出现，但在有足够支持的情况下，人们仍然会积极看待这段经历，因为他们认为整合这些情绪状态带来的额外洞察力很有价值哦[1][6]。

情绪强化最常在中等剂量的迷幻化合物影响下被诱发，比如LSD、赛洛西宾和麦斯卡林[1][2][3][4][6]。不过嘛，它也可能在大麻类、GABA能抑制剂[7][8]和兴奋剂的影响下出现[5][9]。

体验报告

在我们的体验报告中，描述了这种效应的轶事报告包括：

  • Experience: 1 tab 1P-LSD (oral) - Finding myself within the forest_-_Finding_myself_within_the_forest)
  • Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus_-_A_pleasant_low-dose_evening_with_Nexus)
  • Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)/_100ug_1P-LSD(sublingual)-_My_first_time_tripping_alone(2_days_in_a_row))
  • Experience: 6mg:DOC - Carpet shop hell
  • Experience: LSD (Unknown dosage) - My experiences with LSD and anorexia/bulemia_-_My_experiences_with_LSD_and_anorexia/bulemia)
  • Experience:1 hit LSD (unknown dosage) - Choose Asia_-_Choose_Asia)
  • Experience:120mg - Garden of The Gods
  • Experience:120µg LSD - First Bad Acid Trip, Psychosis
  • Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
  • Experience:1g of stars and love
  • Experience:1mg 25c-NBOMe - Experiment in my room
  • Experience:2 grams Psilocybe Cubensis + 2.7 grams Syrian Rue - The Psilohuasca Albino Fox
  • Experience:2 x 150 LSD tabs
  • Experience:2.5g - Swim's first mushroom trip
  • Experience:2.5g Peganum Harmala + 250µg LSD - Ecstasy of Love and Misanthropy
  • Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity))
  • Experience:20mg (insufflated) - I was overcome with feelings about my family_-_I_was_overcome_with_feelings_about_my_family)
  • Experience:20mg - I looked up and saw an angry god-like figure made of clouds glaring down at me
  • Experience:20mg - Relationship problems
  • Experience:225ug - Sheer Awe and Joy
  • Experience:250 seeds - Harsh body load
  • Experience:25mg DMT - Your wall can't save you
  • Experience:2mg 25C-NBOMe - Experimental trip to test personal limits of NBOMes
  • Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
  • Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
  • Experience:300µg AL-LAD - Don't worry, because you're everyone!
  • Experience:300µg LSD - Togetherness and the Silent Dusk
  • Experience:337mg DMT fumarate - A Day With DMT
  • Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
  • Experience:5g Mushrooms - Failed attempt at a Terence Mckenna style trip.
  • Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
  • Experience:70 mg - Overcoming personal problems
  • Experience:800ug LSD - 3D Vision
  • Experience:Into the Multiverse
  • Experience:LSD (230 ug) - An amazing adventure by vikilikepsych_-_An_amazing_adventure_by_vikilikepsych)
  • Experience:LSD (400ug, Oral) - An afternoon in "a" garden_-An_afternoon_in%22a%22_garden)
  • Experience:LSD (~500μg, sublingual) + Noopept - Mind Reset_%2B_Noopept_-_Mind_Reset)
  • Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams))
  • Experience:Unknown dose - Supermarket dislocation and biking
  • Experience:~150mg MDA(oral) - a case of mistaken identity_-_a_case_of_mistaken_identity)

另见

外部链接

参考文献

  1. ↑ 1.0 1.1 1.2 1.3 1.4 Gasser, Peter; Kirchner, Katharina; Passie, Torsten (2014). "LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects". Journal of Psychopharmacology. 29 (1): 57–68. doi:10.1177/0269881114555249. ISSN 0269-8811.
  2. ↑ 2.0 2.1 2.2 Kaelen, M.; Barrett, F. S.; Roseman, L.; Lorenz, R.; Family, N.; Bolstridge, M.; Curran, H. V.; Feilding, A.; Nutt, D. J.; Carhart-Harris, R. L. (2015). "LSD enhances the emotional response to music". Psychopharmacology. 232 (19): 3607–3614. doi:10.1007/s00213-015-4014-y. ISSN 0033-3158.
  3. ↑ 3.0 3.1 3.2 Hartogsohn, Ido (2018). "The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity". Frontiers in Neuroscience. 12. doi:10.3389/fnins.2018.00129. ISSN 1662-453X.
  4. ↑ 4.0 4.1 4.2 4.3 Swanson, Link R. (2018). "Unifying Theories of Psychedelic Drug Effects". Frontiers in Pharmacology. 9. doi:10.3389/fphar.2018.00172. ISSN 1663-9812.
  5. ↑ 5.0 5.1 Miller, Melissa A.; Bershad, Anya K.; de Wit, Harriet (2015). "Drug effects on responses to emotional facial expressions". Behavioural Pharmacology. 26 (6): 571–579. doi:10.1097/FBP.0000000000000164. ISSN 0955-8810.
  6. ↑ 6.0 6.1 6.2 6.3 Belser, Alexander B.; Agin-Liebes, Gabrielle; Swift, T. Cody; Terrana, Sara; Devenot, Neşe; Friedman, Harris L.; Guss, Jeffrey; Bossis, Anthony; Ross, Stephen (2017). "Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis". Journal of Humanistic Psychology. 57 (4): 354–388. doi:10.1177/0022167817706884. ISSN 0022-1678.
  7. ↑ Kamboj, Sunjeev K.; Joye, Alyssa; Bisby, James A.; Das, Ravi K.; Platt, Bradley; Curran, H. Valerie (2012). "Processing of facial affect in social drinkers: a dose–response study of alcohol using dynamic emotion expressions". Psychopharmacology. 227 (1): 31–39. doi:10.1007/s00213-012-2940-5. ISSN 0033-3158.
  8. ↑ Philippot, Pierre; Kornreich, Charles; Blairy, Sylvie; Baert, Iseult; Dulk, Anne Den; Bon, Olivier Le; Streel, Emmanuel; Hess, Ursula; Pelc, Isy; Verbanck, Paul (1999). "Alcoholics'Deficits in the Decoding of Emotional Facial Expression". Alcoholism: Clinical and Experimental Research. 23 (6): 1031–1038. doi:10.1111/j.1530-0277.1999.tb04221.x. ISSN 0145-6008.
  9. ↑ Wardle, Margaret C.; Garner, Matthew J.; Munafò, Marcus R.; de Wit, Harriet (2012). "Amphetamine as a social drug: effects of d-amphetamine on social processing and behavior". Psychopharmacology. 223 (2): 199–210. doi:10.1007/s00213-012-2708-y. ISSN 0033-3158.